MedTrace Logo

Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps

NCT04160832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-01-15

No results posted yet for this study

Summary

The study is being conducted to determine the prevalence and risk factors for germline cancer susceptibility genetic mutations among patients with advanced colorectal polyps.

Conditions

  • Colorectal Neoplasm

Interventions

GENETIC

Multi-Cancer Cancer Panel

Eligible patients will receive genetic testing to determine germline cancer predisposition.

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Swati Patel, MD · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-24
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04160832 on ClinicalTrials.gov